Article

Rheumatoid Arthritis Quiz: Treat-to-Target

Author(s):

Ingrid Torjesen

Treat-to-target remains a key strategy for the treatment of rheumatoid arthritis. However, some changes to the recommendations were made in the 2021 American College of Rheumatology Guidelines on the Management of Rheumatoid Arthritis. Check your knowledge on how to approach a treat-to-target strategy with this quiz.

In which of these groups does the 2021 American College of Rheumatology Guidelines on the Management of Rheumatoid Arthritis strongly recommend a treat-to-target strategy over a non-targeted approach?


Related Videos
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Comparing Treatment Options for Psoriatic Arthritis with Philip Mease, MD
Considering Viral Infections in Patients With Rheumatic Disease With Leonard Calabrese, DO
Leonard H. Calabrese, DO, Professor of Medicine and Vice Chair, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Alvin Wells, MD, PhD: Making Informed Treatment Decisions With New Testing Strategies
Alvin Wells, MD, PhD
Upcoming Research in PsA, AxSpa, with Philip Mease, MD
Philip Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
Related Content
Lauma Ievina, PhD candidate, The Institute of Microbiology and Virology of the Riga Stradiņš University Science Hub, Latvia
October 18th 2024

Study Identifies Gut Microbiome Makeup, Diversity Differences in People With Fibromyalgia

Victoria Johnson
Emerging Agents in the Treatment of Rheumatic Diseases
October 2nd 2023

Emerging Agents in the Treatment of Rheumatic Diseases

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR Philip J. Mease, MD
Tonix Pharma Submits NDA for TNX-102 SL, Potential Fibromyalgia Medication
October 16th 2024

Tonix Pharma Submits NDA for TNX-102 SL, Potential Fibromyalgia Medication

Victoria Johnson
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis
August 31st 2023

Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR John B. Boone, MD, FACR Madelaine Feldman MD, FACR
Etanercept, Infliximab Biosimilars Not Linked to Greater Infection Risks
October 14th 2024

Etanercept, Infliximab Biosimilars Not Linked to Greater Infection Risks

Kevin Kunzmann
Philip J. Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
October 14th 2024

Guselkumab Yields Durable Improvements in Psoriatic Arthritis

Victoria Johnson
© 2024 MJH Life Sciences

All rights reserved.